Current affiliation: University of ShizuokaSubject speciality: Medicine And Medical SciencesPrimary location: Japan
Published in:Thrombosis ResearchPublication date:2015-05-01
Published in:The Pharmacogenomics JournalPublication date:2016-05-31
Published in:Therapeutic Drug MonitoringPublication date:2016-06-01
Published in:European Journal of Clinical PharmacologyPublication date:2016-01-20
Published in:Biological & Pharmaceutical BulletinPublication date:2016-01-01
Published in:European Journal of Clinical PharmacologyPublication date:2016-07-09
Tolvaptan is an orally active selective vasopressin V2 receptor antagonist that increases free-water clearance without electrolyte secretion.
Published in:SeizurePublication date:2015-12-01
Published in:Drug Metabolism and PharmacokineticsPublication date:2015-06-01
Published in:Journal of Pharmaceutical and Biomedical AnalysisPublication date:2014-02-01
Published in:Drug Metabolism and PharmacokineticsPublication date:2013-01-01
Published in:Biological & Pharmaceutical BulletinPublication date:2008-01-01
Published in:Therapeutic Drug MonitoringPublication date:2016-09-01
The risk factors for augmented renal clearance (ARC) were assessed in 292 patients.
The influences of ARC on vancomycin (VCM) treatment were also e...